These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2953546)

  • 1. Characterization studies of human tissue-type plasminogen activator produced by recombinant DNA technology.
    Vehar GA; Spellman MW; Keyt BA; Ferguson CK; Keck RG; Chloupek RC; Harris R; Bennett WF; Builder SE; Hancock WS
    Cold Spring Harb Symp Quant Biol; 1986; 51 Pt 1():551-62. PubMed ID: 2953546
    [No Abstract]   [Full Text] [Related]  

  • 2. Quality control of rDNA-derived human tissue-type plasminogen activator.
    Jones AJ; Garnick RL
    Bioprocess Technol; 1990; 10():543-66. PubMed ID: 1367501
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel recombinant tissue plasminogen activators produced in Escherichia coli.
    Saito Y; Sasaki H; Hayashi M; Suzuki S; Ishii Y; Koyama S; Notani J; Kobayashi M; Asada T; Horiai H
    Ann N Y Acad Sci; 1990; 613():452-4. PubMed ID: 2127520
    [No Abstract]   [Full Text] [Related]  

  • 4. Cloning of cDNA coding for human tissue-type plasminogen activator and its expression in Escherichia coli.
    Harris TJ; Patel T; Marston FA; Little S; Emtage JS; Opdenakker G; Volckaert G; Rombauts W; Billiau A; De Somer P
    Mol Biol Med; 1986 Jun; 3(3):279-92. PubMed ID: 3090401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue plasminogen activator has an O-linked fucose attached to threonine-61 in the epidermal growth factor domain.
    Harris RJ; Leonard CK; Guzzetta AW; Spellman MW
    Biochemistry; 1991 Mar; 30(9):2311-4. PubMed ID: 1900431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of tissue plasminogen activator kringle-2 domain expressed in Escherichia coli.
    Cleary S; Mulkerrin MG; Kelley RF
    Biochemistry; 1989 Feb; 28(4):1884-91. PubMed ID: 2497771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. rtPA is a well-characterized protein.
    O'Connor JV
    Dev Biol Stand; 1998; 96():113-21. PubMed ID: 9890524
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and secretion of a fibrinolytically active tissue-type plasminogen activator variant in Escherichia coli.
    Waldenström M; Holmgren E; Attersand A; Kalderén C; Löwenadler B; Rådén B; Hansson L; Pohl G
    Gene; 1991 Mar; 99(2):243-8. PubMed ID: 1902433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression, purification, and characterization of the recombinant kringle 1 domain from tissue-type plasminogen activator.
    DeSerrano VS; Menhart N; Castellino FJ
    Arch Biochem Biophys; 1992 Apr; 294(1):282-90. PubMed ID: 1550352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human tissue-type plasminogen activator synthesized by using a baculovirus vector in insect cells compared with human plasminogen activator produced in mouse cells.
    Steiner H; Pohl G; Gunne H; Hellers M; Elhammer A; Hansson L
    Gene; 1988 Dec; 73(2):449-57. PubMed ID: 3149610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-level expression of recombinant genes in Escherichia coli is dependent on the availability of the dnaY gene product.
    Brinkmann U; Mattes RE; Buckel P
    Gene; 1989 Dec; 85(1):109-14. PubMed ID: 2515992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble expression, purification, and characterization of active recombinant human tissue plasminogen activator by auto-induction in E. coli.
    Long X; Gou Y; Luo M; Zhang S; Zhang H; Bai L; Wu S; He Q; Chen K; Huang A; Zhou J; Wang D
    BMC Biotechnol; 2015 Mar; 15():13. PubMed ID: 25886739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression analysis and purification of human recombinant tissue type plasminogen activator (rt-PA) from transgenic tobacco plants.
    Nabiabad HS; Yaghoobi MM; Javaran MJ; Hosseinkhani S
    Prep Biochem Biotechnol; 2011; 41(2):175-86. PubMed ID: 21442553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells.
    Lawrence D; Strandberg L; Grundström T; Ny T
    Eur J Biochem; 1989 Dec; 186(3):523-33. PubMed ID: 2514093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of a biologically active variant form of recombinant human secretin.
    Olson H; Lind P; Pohl G; Henrichson C; Mutt V; Jörnvall H; Josephson S; Uhlén M; Lake M
    Peptides; 1988; 9(2):301-7. PubMed ID: 3287357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cloning, isolation and characterization of a biologically active human enzyme, urokinase, in E. coli.
    Hung PP
    Adv Exp Med Biol; 1984; 172():281-93. PubMed ID: 6375302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing structure-function relationships of tissue-type plasminogen activator by oligonucleotide-mediated site-specific mutagenesis.
    Madison EL; Sambrook JE
    Methods Enzymol; 1993; 223():249-71. PubMed ID: 8271957
    [No Abstract]   [Full Text] [Related]  

  • 18. Cloning and characterization of a cDNA for rat tissue-type plasminogen activator.
    Ny T; Leonardsson G; Hsueh AJ
    DNA; 1988 Dec; 7(10):671-7. PubMed ID: 3148445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A bifunctional hybrid molecule of the amino-terminal fragment of urokinase and domain II of bikunin efficiently inhibits tumor cell invasion and metastasis.
    Kobayashi H; Sugino D; She MY; Ohi H; Hirashima Y; Shinohara H; Fujie M; Shibata K; Terao T
    Eur J Biochem; 1998 May; 253(3):817-26. PubMed ID: 9654084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased yield of human tissue-type plasminogen activator obtained by means of recombinant DNA technology.
    Browne MJ; Dodd I; Carey JE; Chapman CG; Robinson JH
    Thromb Haemost; 1985 Aug; 54(2):422-4. PubMed ID: 3936214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.